2321 High response rate and progression free survival with PEGylated recombinant human hyaluronidase added to Nab-Paclitaxel/ Gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized Phase 2 study. (September 2015)

• Record Type: Journal Article
• Authors: Hingorani, S.; Harris, W.; Hendifar, A.; Bullock, A.; Wu, X.; Huang, Y.; Jiang, P.; Hoff, D. Von
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S439
• Page End: S440
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)31237-0
• Languages: English
• ISSNs: 0959-8049